Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
Catenin
100%
Programmed Cell Death
84%
Nuclear Receptor
79%
Colon
73%
Cancer Cell
62%
Cell Cycle
61%
Estrogen Receptor
61%
Transcription Initiation
51%
Transactivation
51%
Gene Activation
49%
Androgen Receptor
49%
Carcinogenesis
48%
Promoter Region
47%
CARM1
43%
C-Terminus
31%
Mesenchymal-Epithelial Transition
31%
Nuclear Receptor Coactivator
30%
Protein-Protein Interaction
30%
Protein Methylation
30%
DNA Binding
29%
Sirtuin1
28%
Overall Survival
27%
Wnt Signaling Pathway
26%
Methylotrophic Bacterium
24%
Computer Assisted Tomography
24%
Epidermal Growth Factor Receptor
24%
Bilirubin
24%
Mediator Complex
24%
Disease Free Survival
24%
Sumoylation
24%
Serratia marcescens
24%
Morphology
24%
Cancer Growth Factor
24%
Anchorage Independent Growth
24%
Cancer Specific Survival
24%
Phlebothrombosis
24%
Growth Factor Signaling
24%
Progression Free Survival
24%
Cell Count
24%
Alpha-Fetoprotein
24%
Claudin
24%
Aspartate Transaminase
24%
BRCA1 Protein
24%
Multidetector Computed Tomography
24%
SMYD3
24%
Heat Shock Transcription Factor 1
24%
Drive
24%
Small Interfering RNA
18%
Transcription Factor
18%
Transcription
16%
Medicine and Dentistry
Esophageal Squamous Cell Carcinoma
73%
Chronic Hepatitis C
49%
Ribavirin
49%
Gallbladder Cancer
49%
Breast Cancer
49%
Biological Marker
40%
Carcinogenesis
28%
Peginterferon
26%
Combination Therapy
26%
Programmed Cell Death
24%
Receptor
24%
Cholecystitis
24%
Zinc Finger Protein
24%
Skin Manifestation
24%
Integrin
24%
Colorectal Carcinoma
24%
Soft Tissue Metastasis
24%
Hepatocellular Carcinoma
24%
Platelet
24%
Circulating Tumor Cell
24%
Maspin
24%
Patient with Solid Organ Transplantation
24%
Intraductal Papillary Mucinous Tumor
24%
Hazard Ratio
24%
Clear Cell Renal Cell Carcinoma
24%
Overall Survival
24%
Invasive Carcinoma
20%
Prognostic Factor
18%
Immunohistochemistry
17%
Disease Free Survival
16%
Transaminase
16%
Adverse Event
16%
Epidermal Growth Factor Receptor 2
16%
Gamma Urogastrone
16%
Carboxy Terminal Sequence
12%
Cancer Growth Factor
12%
Mucinous Carcinoma
12%
Cancer
12%
Recurrence Free Survival
10%
Aspartate Aminotransferase
10%
Adenoma
10%
Dysplasia
10%
Carbetimer
8%
Carcinoma in Situ
8%
Elderly Patient
8%
Multivariate Analysis
8%
Computer Assisted Tomography
7%
Multidetector Computed Tomography
7%
Antigen Response
7%
Neoplasm
6%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
55%
Cancer Growth
49%
Biological Marker
36%
Colorectal Carcinoma
27%
Gefitinib
24%
Patient History of Chemotherapy
24%
Lung Cancer
24%
Erlotinib
24%
Integrin
24%
Estrogen Receptor Negative Breast Cancer
24%
Colon Carcinoma
24%
Mitogen Activated Protein Kinase
24%
Bruceantin
24%
Catenin
24%
Brucea
24%
Liver Cell Carcinoma
24%
Colorectal Tumor
24%
Claudin 4
24%
Interstitial Collagenase
24%
Esophagus Cancer
24%
Gamma Urogastrone
24%
Soft Tissue Metastasis
24%
Acute Liver Failure
24%
Epidermal Growth Factor Receptor 2
24%
Renal Cell Carcinoma
24%
Estrogen Receptor
24%
Esophageal Squamous Cell Carcinoma
24%
Prostate Cancer
24%
Heat Shock Transcription Factor 1
24%
Overall Survival
24%
Disease Free Survival
16%
Quassinoid
14%
Cancer Growth Factor
12%
Adenoma
12%
Colorectal Adenoma
12%
Castration Resistant Prostate Cancer
9%
Diseases
7%
Esophagus Carcinoma
7%
Transcription Factor
6%
Progression Free Survival
6%
Bilirubin
6%
Portal Vein Thrombosis
6%
Aspartate Aminotransferase
6%
Alpha Fetoprotein
6%
BRCA1 Protein
6%